Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |